Six months ago, we proudly announced our partnership with Save the Cord Foundation in launching an awareness campaign called “Cord Blood Banking Awareness: Educating America and the World.” This campaign aims to educate currently expecting parents, as well as future parents, grandparents, siblings, and friends, about the medical benefits of cord blood preservation. Below is a collection of facts that aid our efforts in spreading awareness.
Will Cord Blood Banking be the Next Trend in BioBanking?
A biobank is a repository that stores biological samples (usually human) for use in research and medicine. The registration of each sample entering and exiting the system is centrally stored on a computer system that is frequently backed up, and the physical location of each sample is noted to allow efficient location of specimens. Storage of the specimens may range from controlled ambient (room temperature), to +4°C, -20°C, -80°C, and -196°C (liquid or vapor nitrogen, LN2).
CarePilot and “Cord for Life” Find Innovative Way to Make Cord Blood Banking Affordable
In August 2014, CarePilot USA, based in Newport Beach, California, announced a collaboration with the “Cord for Life” storage program offered by Lifeforce Cryobanks, a company based in Altamonte Springs, Florida. Through this partnership, CarePilot is now offering significant discounts on the collection, processing, and storage of newborn umbilical cord blood. Specifically, CarePilot is offering two, six, and 21-year storage plans at major discounts relative to the market rates offered by the “Cord for Life” program. [Read more…]
CBR® Acquisition by AMAG Pharma Further Bolsters Cord Blood Investment Environment
The past few years have seen increasing investments made within the cord blood banking market, both by private equity and venture capital firms. These investments show the strength of the cord blood banking market. A summary of these investors is shown below.
There have also been significant acquisitions made within the cord blood industry, with the largest cord blood bank within the United States, Cord Blood Registry, recently acquired by AMAG Pharmaceuticals in June of 2015 for $700 million. The purchase valued Cord Blood Registry at over 5.55 times revenue and over 15.55 times EBITDA. [Read more…]
Major Industry Alliance: CariCord and ClinImmune Labs Partner with International Space Medicine Consortium
AUTHOR: Authored by Wendy Roberts, PR Director of Orca Communications Unlimited, LLC.
COMMENT BY BIOINFORMANT: Leading global players within cord blood industry frequently attain their industry dominance through industry collaborations. In the announcement below, released May 11, 2015, CariCord and ClinImmune Labs announce a major industry partnership that will study the survivability of umbilical cord blood stem cells under micro gravity (Micro-G) simulation.
CariCord, a private stem cell bank at the University of Colorado, is a FDA-licensed cord blood manufacturer that has processed nearly 9,000 cord blood units and released 700+ for transplantation across 150+ hospitals worldwide. While CariCord is not as substantial in size as other key players within the U.S. cord blood industry (most notably Cord Blood Registry, ViaCord, and Cryo-Cell, respectively) the company is positioning itself for increased visibility and growth through this strategic collaboration. [Read more…]